Creative Planning’s TuHURA Biosciences HURA Stock Holding History

Creative Planning’s Portfolio HURA Stock Details HURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$66.4K	Sell	28,397 -2,497	-8%	-$5.82K	﹤0.01%	4086
2026 Q1	$55.3K	Buy	+30,894	New	+$37.9K	﹤0.01%	3974
2025 Q4	–	Sell	-23,094	Closed	-$57.3K	–	4140
2025 Q3	$57.3K	Buy	+23,094	New	+$60.8K	﹤0.01%	3746
2018 Q2	–	Sell	-2	Closed	-$33K	–	2187
2018 Q1	$33K	Hold	2	–	–	﹤0.01%	1858
2017 Q4	$33K	Buy	+2	New	+$31K	﹤0.01%	1826

Other funds holding HURA

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Creative Planning's HURA Position: Q2 2026 in Review

Creative Planning reduced its TuHURA Biosciences (HURA) stake by 8.1% in Q2 2026, selling an estimated $5.82K and leaving 28,397 shares worth $66.4K. The position accounts for ﹤0.01% of the portfolio, ranked #4086.

Creative Planning first reported a position in HURA in Q4 2017 and has held it in 5 quarters since. 90 funds tracked by Wall St. Rank hold HURA as of Q2 2026.

Creative Planning held 28,397 shares of TuHURA Biosciences worth $66.4K as of Q2 2026.
Creative Planning sold 2,497 TuHURA Biosciences shares in Q2 2026, an estimated $5.82K.
TuHURA Biosciences made up ﹤0.01% of Creative Planning's portfolio in Q2 2026, its #4086 holding.
Creative Planning first reported a position in TuHURA Biosciences in Q4 2017 and has held it in 5 quarters since.
90 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2026.

Based on Creative Planning's 13F filing for Q2 2026, filed 13 Aug 2026.